Tag Archives: big pharma

Cancer Cured … But Not Funded

Posted on by

This is how things are.

In 2010, a Canadian researcher created a product called DCA, a treatment which would significantly reduce cancer incidence and tumours with test animals.

Say what?  2010?  And it hasn’t hit the market?

Well, duh.  Why should it when there are billions to be made with chemo treatments, expensive hardware, a lifetime’s worth of pharmaceutical prescriptions and so on?

This is the sad state of where we are.  Cancers caused by our surroundings and no one willing to end it because there’s no money in it.


Maybe we really should follow up on some of the recommendations in the comments and do a KickStarter campaign for the treatment.

Quebec Outbreak: High Rate of Measle Infection Despite Vaccinations

Posted on by 1 comment

More than 50% of kids who got the measles in a recent Quebec outbreak (52 of 98) were vaccinated.

Meanwhile, we shove buckets of cash into vaccination programs without fully understanding the contents of these products and the budget implications of holding back on vaccinations.

It’s time we all started asking some serious questions about why we’re doing this to our kids.

Canada’s Medicare: Shattering the ‘Unsustainability’ Myth

Posted on by 0 comment

This report by Canadian Doctors for Medicare is a must read for those who are interested in health or who pay taxes.

In other words, if you’re a Canadian citizen.

The key quote and takeaway (bold, italics mine):

While the cost of Medicare has not grown as a percent of GDP over the last 35 years, there have
been significant increases in total health care system costs over the same period, and those
increases have accelerated in the last decade. Overall health spending in Canada has risen from
about 7% of GDP in 1975 to about 10.7% in 2008. In 2010, health care spending was estimated

to be about 12% of GDP.

If Medicare costs are stable, and public sector costs are rising slowly, why are total health care
costs increasing rapidly? The real cost driver is precisely the thing that critics of Medicare tout as
the solution: private health care.

Currently 30% of all health spending is in the private sector, up from 24% in 1975.  That growth
is a result of significant increases in costs in the private health care sector, including out‐of‐pocket
spending and the costs of private insurance. Pharmaceuticals and private prescription drug
insurance are the most significant driver of these costs
, followed by dental care and private
dental insurance.

The overall cost of care has been driven most significantly by the rising cost of pharmaceuticals. In
fact, the rising share of privately financed health care would be much more modest were it not
for the impact of pharmaceutical costs. Canada’s drug costs are higher than the per capita costs
of all Organisation for Economic Co‐operation and Development (OECD) countries with the
exception of the United States and Switzerland, and 30% higher than the OECD average.  Drug
costs overall rose from $4 billion in 1985 to an estimated $26.5 billion in 2007.  During that time, Canadian drug prices rose an average of 9.2%, far faster than in any other OECD country.

In other words, we’re getting hosed, folks. Mega-pharma companies are using Canada’s health care system to line their pockets and it has to stop.